The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: velcade     Quarter: 2016Q3

Total Records: 602     Number of Pages: 31

DRUGNAME PT EventCount
VELCADE Inappropriate antidiuretic hormone secretion 6
VELCADE Muscular weakness 6
VELCADE Musculoskeletal chest pain 6
VELCADE Nasopharyngitis 6
VELCADE Acute pulmonary oedema 5
VELCADE Blood alkaline phosphatase increased 5
VELCADE Cardiac amyloidosis 5
VELCADE Cardiomyopathy 5
VELCADE Clostridium difficile infection 5
VELCADE Deep vein thrombosis 5
VELCADE Dry skin 5
VELCADE Feeling abnormal 5
VELCADE Gastrointestinal infection 5
VELCADE Guillain-Barre syndrome 5
VELCADE Hyperglycaemia 5
VELCADE Influenza 5
VELCADE Large intestine perforation 5
VELCADE Leukopenia 5
VELCADE Lung disorder 5
VELCADE Neurotoxicity 5

Total Records: 602     Number of Pages: 31